-
Felmingham, B, Collier, L, Stenta, T, Halman, A, Sadedin, S, Moore, C, Elliott, D, Conyers, R.
MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children.
Pathology
55:
s17 -s18
2023
view publication
-
Felmingham, B, Collier, L, Stenta, T, Halman, A, Sadedin, S, Moore, C, Elliott, D, Conyers, R.
MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children.
Pathology
55:
s6
2023
view publication
-
Perram, J, Purtill, D, Bajel, A, Butler, J, O'Brien, T, Teh, B, Gilroy, N, Ho, PJ, Doocey, R, Hills, T, et al.
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell..
Intern Med J
53(1)
:
119 -125
2023
view publication
-
Nielsen, CG, Thomsen, BL, Als-Nielsen, B, Conyers, R, Jeha, S, Mateos, MK, Mlynarski, W, Pieters, R, Rathe, M, Schmiegelow, K, et al.
Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment..
Front Pediatr
11:
1155449
2023
view publication
-
Walker, H, Esbenshade, AJ, Dale, S, Bhatia, K, Zhao, Z, Babl, FE, Conyers, R, Haeusler, GM.
Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation..
Pediatr Blood Cancer
69(12)
:
e29931
2022
view publication